Case Study – Pediatrics Study In Mucopolysaccharidosis Type III (MPSIIIA)
Discover how our scientists performed an open, non-controlled, parallel, ascending multiple-dose, multicentre…
Read more
Flyer – SARS-Cov-2 ELISpot: A New Test In The Covid-19 Diagnostic And Vaccine Arsenal
Following SARS-CoV-2 infection, an innate immune response occurs rapidly at the infection…
Read more
Case Study – Tech Transfer China For IFE Reflex Assay
Biotech Company in China required our scientific expertise for the Tech Transfer…
Read more
Flyer – Turning Precision Medicine Into Action
CerbACT Asia empowers precision medicine development and drives better patient outcomes by…
Read more
Publication – Measurable Success: The Value Of Biomarkers From Discovery Through Commercialization
Why do some patients respond to therapy while others do not? The…
Read more
Poster – Solid Tumor Analytical Validation Of A T-Regulatory Immunohistochemistry Multiplex For Clinical Studies
Accurate characterization of the tumor micro-environment when tissue sample access is limited…
Read more
Publication – Change The Shape Of Your Clinical Development
At Cerba Research we are built on more than 50 years of…
Read more
Article – The New Big Data Application That Is Reshaping Clinical Trials
The new big data application is reshaping clinical trials. Someone on the…
Read more
Case Study – Phase 3 CAR-T vs SOC In Relapse Refractory Multiple Myeloma (RRMM)
Discover how effective we are in immunophenotyping for a Car-T therapy take…
Read more
Case Study – Phase 1 Dose Escalation Study With A Bispecific Antibody In Relapse Refractory Multiple Myeloma (RRMM)
Discover how we manage routine and specialty test for a Phase 1…
Read more
Case Study – Phase 2 To Determine Safety And Efficacy Of A mAB CKI Combo In Relapse Refractory Multiple Myeloma (RRMM)
Discover how we managed cell isolation and counts among other routine and…
Read more
Article – The Value Of Biomarkers From Discovery To Commercialization
Why do some patients respond to therapy while others do not? The…
Read more
Article – Cerba Research Expands U.S. Immuno-Oncology Center Of Excellence To Strengthen Its Precision Medicine Offerings
Cerba Research established its United States presence as a leading clinical diagnostics…
Read more
Case Study – How Cerba Research Helped Advance A Phase 1B Study In The Middle Of A Pandemic And Brexit
A two-country clinical trial that involves a nasopharyngeal swab and two assays…
Read more
Case Study – Tech Transfer IFE Reflex Assay China
A Biotech Company in China required our scientific expertise for the Tech…
Read more
Case Study – Pediatric Phase I/II/III Study In X-Linked Myotubular Myopathy (XLMTM)
Lab support for a global pediatric trial for the rare neuromuscular disease,…
Read more
Case Study – Pediatric Phase I/II Clinical Trial on Mucopolysaccharidosis type III (MPSIIIA)
Lab support for a global pediatric trial for the rare genetic neurodegenerative…
Read more
Case Study – Lab Support For The Largest Global Phase III NASH Study To Date
In a meta-analysis of several studies using various methodologies, worldwide prevalence of…
Read more
Case Study – Ten-Day Study Start & Customer Test Kit Build at the Height of a Pandemic
On the upswing of the COVID-19 pandemic, an ID focused pharmaceutical client…
Read more
Together, we can shape the future of your clinical development. Find out more about how we can support your research.